Inhibitory effect and mechanism of hirsuteine on NCI‑H1299 lung cancer cell lines
X Yun, H Qin, B Du, Y Peng, Y Liu… - Oncology …, 2023 - spandidos-publications.com
Traditionally, the bark of Uncaria rhynchophylla (UR) has been employed for the treatment of
hypertension, cancer, convulsions, haemorrhage, autoimmune disorders and other ailments …
hypertension, cancer, convulsions, haemorrhage, autoimmune disorders and other ailments …
Evolution of surgical treatment of metastatic spine tumors
Purpose The treatment of cancer has transformed over the past 40 years, with medical
oncologists, radiation oncologists and surgeons working together to prolong survival times …
oncologists, radiation oncologists and surgeons working together to prolong survival times …
Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A …
R Tomida, M Takahashi, Y Matsushita, T Kojima… - Clinical Genitourinary …, 2024 - Elsevier
Background To date, no studies have compared the treatment outcomes of second-line
therapies in patients with metastatic clear cell renal cell carcinoma (ccRCC). This study …
therapies in patients with metastatic clear cell renal cell carcinoma (ccRCC). This study …
Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment
K Tada, K Daizumoto, M Takahashi, H Uehara… - IJU Case …, 2023 - Wiley Online Library
Introduction A case of multiple liver metastases of clear cell RCC with a significant response
to sunitinib as the fifth line after nivolumab is reported. Case presentation The patient was a …
to sunitinib as the fifth line after nivolumab is reported. Case presentation The patient was a …
Real‐world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST‐NIVO study): 36‐month follow‐up …
J Yonese, N Hinata, S Masui, Y Nakai… - … Journal of Urology, 2023 - Wiley Online Library
Objectives To examine the long‐term effectiveness of nivolumab monotherapy and following
subsequent therapies for metastatic renal cell carcinoma (mRCC) in Japanese real‐world …
subsequent therapies for metastatic renal cell carcinoma (mRCC) in Japanese real‐world …
[HTML][HTML] Successful apatinib treatment for advanced clear cell renal carcinoma as a first-line palliative treatment: A case report
HP Wei, J Mao, ZL Hu - World Journal of Clinical Cases, 2022 - ncbi.nlm.nih.gov
BACKGROUND Apatinib is an orally bioavailable small-molecule receptor tyrosine kinase
inhibitor. In December 2014, the China Food and Drug Administration made it the first anti …
inhibitor. In December 2014, the China Food and Drug Administration made it the first anti …